TN1557 |
Decursinol angelate
|
130848-06-5
|
99.65%
|
|
Decursinol angelate has anti-tumor, anti-inflammatory, anti-oxidant, and hepatoprotective activities, it inhibits VEGF-induced angiogenesis via suppression of th...
|
T6137 |
KRN-633
|
286370-15-8
|
99.65%
|
|
KRN-633 is an effective VEGFR inhibitor. The IC50s of KRN-633(KRN633) for VEGFR1, VEGFR2, and VEGFR3 is 170, 160 and 125 nM, respectively.
|
T6730 |
WAY-600
|
1062159-35-6
|
99.63%
|
|
WAY-600 is a potent, ATP-competitive and selective inhibitor of mTOR with IC50 of 9 nM; blocks mTORC1/P-S6K(T389) and mTORC2/P-AKT(S473) but not P-AKT(T308); sel...
|
T4209 |
TAK-659 hydrochloride
|
1952251-28-3
|
99.63%
|
|
TAK-659 hydrochloride (TAK-659) is a potent and selective inhibitor of spleen tyrosine kinase (SYK) with an IC50 value of 3.2 nM. It is selective against most ot...
|
T22755 |
(E)-FeCP-oxindole
|
884338-18-5
|
99.62%
|
|
(E)-FeCP-oxindole is an inhibitor of VEGFR2 with IC50 of 214 nM.
|
T0093L |
Sorafenib
|
284461-73-0
|
99.61%
|
|
Sorafenib (Bay 43-9006) is a multikinase inhibitor that inhibits Raf-1, B-Raf, VEGFR2, VEGFR3, VEGFR4, PDGFRβ, FLT3, c-Kit, and others (IC50=6/22/90/15/20/20/57/...
|
T15454 |
GW843682X
|
660868-91-7
|
99.56%
|
|
GW843682X (GW843682) is a selective and ATP-competitive inhibitor of PLK1 and PLK3 (IC50s = 2.2 nM and 9.1 nM).
|
T5466 |
Tyrosine kinase-IN-1
|
705946-27-6
|
99.55%
|
|
Tyrosine kinase-IN-1 is a multi-targeted tyrosine kinase inhibitor(KDR, Flt-1, FGFR1 and PDGFRα with IC50s of 4nM, 20nM, 4nM, 2 nM ,respectively)
|
T2906 |
Tanshinone IIA
|
568-72-9
|
99.54%
|
|
Tanshinone IIA (Tanshinone B)(Tanshinone B) is the diterpene quinone in Danshen, which is utilized in the treatment of cardiovascular and inflammatory.
|
T3980 |
Su1498
|
168835-82-3
|
99.54%
|
|
Su1498 (Tyrphostin SU 1498) is a selective inhibitor of the receptor tyrosine kinase VEGF receptor 2 (VEGFR2, aka FLK1; IC50 = 700 nM), having negligible activit...
|
T1452 |
Axitinib
|
319460-85-0
|
99.53%
|
|
Axitinib (AG-013736) is an orally bioavailable tyrosine kinase inhibitor with IC50s of 0.1, 0.2, 0.1-0.3, 1.7, 1.6 nM for VEGFR1, VEGFR2, VEGFR3, c-kit, and PDGF...
|
T72924 |
VEGFR-3-IN-1
|
2756668-73-0
|
99.52%
|
|
VEGFR-3-IN-1 is a novel potent and selective VEGFR3 inhibitor with an IC50 of 110.4 nM.VEGFR-3-IN-1 possesses antitumor activity, inactivates the VEGFR3 signalin...
|
T9052 |
XL092
|
2367004-54-2
|
99.51%
|
|
XL092 (JUN04542) is an Axl Mer cMet KDR inhibitor for the treatment of Axl and Mer receptor tyrosine kinase- dependent disorders.
|
T22431 |
SU5204
|
186611-11-0
|
99.5%
|
|
SU5204 (3-[(2-Ethoxyphenyl)methylidene]-1H-indol-2-one), an analogue of SU5025, pharmacologically inhibits VEGFR2(IC50s of 4 and 51.5 μM for FLK-1 (VEGFR-2) and ...
|
T4425 |
JK-P3
|
942655-44-9
|
99.5%
|
|
JK-P3 is a pyrazole-based inhibitor of VEGFR-2 (IC50: 7.8 μM). JK-P3 inhibits FGFR 1/3 kinase activity in vitro, but has no effect on FGFR signaling in cell-base...
|
T1991 |
ZM323881 hydrochloride
|
193000-39-4
|
99.5%
|
|
ZM323881 hydrochloride (ZM 323881 HCl) is a potent and selective VEGFR2 inhibitor.
|
T1792L |
Regorafenib monohydrate
|
1019206-88-2
|
99.47%
|
|
Regorafenib Monohydrate is a novel oral multikinase inhibitor with IC50 values of 13, 4.2, 46, 22, 7, 1.5, 2.5, 28, 19 nM for VEGFR1, murine VEGFR2, murine VEGFR...
|
TN1853 |
Lariciresinol
|
27003-73-2
|
99.46%
|
|
Lariciresinol is an enterolignan precursor, it possesses fungicidal activities by disrupting the fungal plasma membrane and therapeutic potential as a novel anti...
|
T0263 |
Chloropyramine hydrochloride
|
6170-42-9
|
99.45%
|
|
Chloropyramine hydrochloride (Alergosan) is a histamine receptor H1 antagonist.
|
T12145L |
N-Desethylsunitinib hydrochloride
|
1261432-05-6
|
99.42%
|
|
N-Desethylsunitinib hydrochloride is a major and pharmacologically active metabolite of sunitinib, which is potent, ATP-competitive VEGFR, PDGFRβ, and KIT inhibi...
|